benzo(a)pyrene-3,6-quinol has been researched along with nalbuphine in 1 studies
Studies (benzo(a)pyrene-3,6-quinol) | Trials (benzo(a)pyrene-3,6-quinol) | Recent Studies (post-2010) (benzo(a)pyrene-3,6-quinol) | Studies (nalbuphine) | Trials (nalbuphine) | Recent Studies (post-2010) (nalbuphine) |
---|---|---|---|---|---|
5 | 0 | 0 | 793 | 269 | 185 |
Protein | Taxonomy | benzo(a)pyrene-3,6-quinol (IC50) | nalbuphine (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.0578 | |
Delta-type opioid receptor | Homo sapiens (human) | 1.1195 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.097 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
1 review(s) available for benzo(a)pyrene-3,6-quinol and nalbuphine
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |